NDC 0143-9720-01 - Levofloxacin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0143-9720
- Requested NDC
- 0143-9720-01
- Package NDCs from labels
- 0143-9720-01, 0143-9720-24
- Manufacturer
- Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A
- Effective date
- 2019-03-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levofloxacin - Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A | Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A | 2019-03-28 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0143-9720-01 | Levofloxacin | 150 mL in 1 BAG | INJECTION, SOLUTION | 150 | 12 | |
| 0143-9720-24 | Levofloxacin | 24 in 1 CARTON | INJECTION, SOLUTION | 24 | 12 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0143-9720-01 | ML - Milliliter | 0143-9720 | 7145c2c4-c04c-4976-9710-f0a34cf662c8 | 1 | 2013-02-13 |
| 0143-9720-24 | ML - Milliliter | 0143-9720 | 89adbbf6-59a9-4b0e-8032-ec80c7dfec8a | 1 | 2013-10-17 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LEVOFLOXACIN | ACTIVE INGREDIENT | 6GNT3Y5LMF | LEVOFLOXACIN INJECTION, SOLUTION [WEST-WARD PHARMACEUTICAL CORP] | 4 | |
| LEVOFLOXACIN ANHYDROUS | ACTIVE MOIETY | RIX4E89Y14 | LEVOFLOXACIN INJECTION, SOLUTION [WEST-WARD PHARMACEUTICAL CORP] | 4 | |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | LX22YL083G | LEVOFLOXACIN INJECTION, SOLUTION [WEST-WARD PHARMACEUTICAL CORP] | 4 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | LEVOFLOXACIN INJECTION, SOLUTION [WEST-WARD PHARMACEUTICAL CORP] | 4 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | LEVOFLOXACIN INJECTION, SOLUTION [WEST-WARD PHARMACEUTICAL CORP] | 4 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LEVOFLOXACIN | LEVOFLOXACIN | Gland Pharma Limited | ba69722b-d7f2-4519-8a63-9ee91294c499 | 2024-09-05 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| Levofloxacin | LEVOFLOXACIN | Bryant Ranch Prepack | 54a02488-586d-4c4e-8a35-68a067bdd6e3 | 2024-08-26 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| levofloxacin | LEVOFLOXACIN | Bryant Ranch Prepack | b7a614b0-f604-48e1-9919-21da8f939d93 | 2024-08-26 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| Dextrose | DEXTROSE MONOHYDRATE | FRESENIUS KABI USA, LLC | 576a22d8-5f2f-497e-80ad-1842ca74bb53 | 2024-08-22 | Warnings, Adverse reactions | LX22YL083G |
| Levofloxacin | LEVOFLOXACIN | Bryant Ranch Prepack | 804ec547-5b89-4fd0-89b3-7445543e563e | 2024-08-20 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| levofloxacin | LEVOFLOXACIN | Zydus Lifesciences Limited | ffa121b8-388f-4d7b-af48-d4aa8d9b5961 | 2024-08-16 | 6GNT3Y5LMF | |
| Dextrose | DEXTROSE MONOHYDRATE | Becton Dickinson and Company | c1f72bce-4bef-49db-a8da-f26a703d6748 | 2024-08-15 | Warnings, Adverse reactions | LX22YL083G |
| Levofloxacin | LEVOFLOXACIN | Camber Pharmaceuticals, Inc. | b43e9b51-568c-4d84-bbd1-d237120056c4 | 2024-08-14 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| Levofloxacin | LEVOFLOXACIN | NuCare Pharmaceuticals, Inc. | 4a405103-41e8-6a1f-e054-00144ff8d46c | 2024-07-19 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| Levofloxacin | LEVOFLOXACIN | Lupin Pharmaceuticals, Inc. | 4be13bd5-0c39-43c3-9232-b1226ccd4dbc | 2024-07-10 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| Levofloxacin | LEVOFLOXACIN | NuCare Pharmaceuticals,Inc. | 631523e7-7d67-0cc3-e053-2a91aa0abb62 | 2024-07-08 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| Levofloxacin | LEVOFLOXACIN | Gland Pharma Limited | 95479f18-76dc-41cf-a359-922febeed0f2 | 2024-07-03 | Boxed warning, Warnings, Adverse reactions | 1665497 1665515 1665507 6GNT3Y5LMF |
| Levofloxacin | LEVOFLOXACIN | Dr. Reddy's Laboratories Limited | 9b59428a-a23a-b2d9-982f-98f8a1ed381f | 2024-06-29 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| levofloxacin | LEVOFLOXACIN | Viona Pharmaceuticals Inc | 0948bff7-efc6-4f0e-a9dd-adca5bdc7fc2 | 2024-06-25 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| Isolyte P in Dextrose | DEXTROSE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, AND POTASSIUM PHOSPHATE, DIBASIC | B. Braun Medical Inc. | 4ea4397c-2fa4-4670-91e6-21ae498c88f7 | 2024-06-24 | Warnings, Adverse reactions | LX22YL083G |
| Levofloxacin | LEVOFLOXACIN | Aurobindo Pharma Limited | 529ac72c-c4a0-4001-8cf9-b94f5bf7265c | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| Levofloxacin | LEVOFLOXACIN IN 5% DEXTROSE | Eugia US LLC | 7d3f83bf-2db7-4657-9538-406adf321ad5 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | 1665497 1665515 1665507 6GNT3Y5LMF |
| Levofloxacin | LEVOFLOXACIN | ANI Pharmaceuticals, Inc. | a894e40b-77e4-439b-b0f8-9a5cc7a1dd90 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| Levofloxacin | LEVOFLOXACIN | Eugia US LLC | 4d400bf9-988f-42ec-93f1-e71a93a324b2 | 2024-06-17 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| Levofloxacin | LEVOFLOXACIN | NuCare Pharmaceuticals,Inc. | 72cb9372-e9f8-3ca1-e053-2a91aa0ad820 | 2024-06-10 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.